CRESCENT BIOPHARMA, INC. - Ordinary Shares, $0.001 par value per share (CBIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2025

Type / Class
Equity / Ordinary Shares, $0.001 par value per share
Symbol
CBIO on Nasdaq
Shares outstanding
27,505,770
Price per share
$15.31
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
11,318,865
Total reported value
$134,581,435
% of total 13F portfolios
0%
Share change
+567,125
Value change
+$2,899,469
Number of holders
40
Price from insider filings
$15.31
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CRESCENT BIOPHARMA, INC. - Ordinary Shares, $0.001 par value per share (CBIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fairmount Funds Management LLC 19% -7.3% $85,103,709 +$37,990,471 5,643,482 +81% Fairmount Funds Management LLC 04 Dec 2025
ForGrowth III PA B.V. 6.1% $25,302,008 1,677,852 ForGrowth III PA B.V. 08 Dec 2025
BIOTECHNOLOGY VALUE FUND L P 10% $18,874,937 1,387,863 BVF PARTNERS L P/IL 30 Jun 2025
TANG CAPITAL MANAGEMENT LLC 5% $8,785,000 700,000 TANG CAPITAL MANAGEMENT, LLC 02 Oct 2025
Logos Global Management LP 4.1% $7,820,000 575,000 Logos Global Management LP 30 Jun 2025

As of 30 Sep 2025, 40 institutional investors reported holding 11,318,865 shares of CRESCENT BIOPHARMA, INC. - Ordinary Shares, $0.001 par value per share (CBIO). This represents 41% of the company’s total 27,505,770 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CRESCENT BIOPHARMA, INC. - Ordinary Shares, $0.001 par value per share (CBIO) together control 41% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 5.1% 1,414,680 +0.03% 0% $16,820,545
Fairmount Funds Management LLC 5% 1,387,866 0% 1.5% $16,501,727
VR ADVISER, LLC 5% 1,387,864 0% 0.93% $16,501,703
BVF INC/IL 5% 1,387,863 0% 0.67% $16,501,691
TANG CAPITAL MANAGEMENT LLC 2.5% 679,824 +1256% 0.31% $8,083,107
VANGUARD GROUP INC 2.4% 657,900 0% $7,822,431
Logos Global Management LP 2.2% 600,000 +8.4% 0.7% $7,134,000
PERCEPTIVE ADVISORS LLC 1.6% 453,686 0% 0.16% $5,394,327
Deep Track Capital, LP 1.6% 453,686 0% 0.15% $5,394,326
Boxer Capital Management, LLC 1.6% 453,686 0% 1.7% $5,394,326
Commodore Capital LP 1.6% 450,829 -0.63% 0.26% $5,360,357
PRICE T ROWE ASSOCIATES INC /MD/ 1.4% 383,595 0% $4,561,000
Driehaus Capital Management LLC 1.1% 302,457 0% 0.03% $3,596,214
Frazier Life Sciences Management, L.P. 0.99% 272,951 -40% 0.1% $3,245,387
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.73% 200,005 +98% 0% $2,378,059
Soleus Capital Management, L.P. 0.73% 200,000 -50% 0.13% $2,378,000
BlackRock, Inc. 0.4% 109,115 +1703% 0% $1,297,377
Jefferies Financial Group Inc. 0.37% 102,714 +279% 0.01% $1,221,269
Blackstone Inc. 0.27% 75,614 0% 0% $899,050
GEODE CAPITAL MANAGEMENT, LLC 0.25% 69,134 0% $822,016
MARSHALL WACE, LLP 0.16% 43,694 0% $519,522
GOLDMAN SACHS GROUP INC 0.13% 36,975 0% $439,633
TWO SIGMA INVESTMENTS, LP 0.1% 28,318 0% $336,701
RENAISSANCE TECHNOLOGIES LLC 0.1% 26,900 0% $319,841
CITADEL ADVISORS LLC 0.09% 25,593 0% $304,301

Institutional Holders of CRESCENT BIOPHARMA, INC. - Ordinary Shares, $0.001 par value per share (CBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 11,318,865 $134,581,435 +$2,899,469 $11.89 40
2025 Q2 10,751,740 $173,532,467 +$173,532,403 $16.14 29